Delivery Order SPE2DB25D3404-SPE2DB26FULTY
- Not listed
- The Defense Logistics Agency awarded a $6,044.85 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitive award uses firm fixed pricing with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency (DLA) awarded a $5,783.00 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens with a completion date of September 9, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will fulfill the order from its corporate office location. Trulicity is a diabetes medication...
- The Defense Logistics Agency awarded a $2,366.00 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price contract is unset-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly supplied through federal medical procurement channels to support military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $3,667.79 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on April 28, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by April 29, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used to improve blood sugar control in patients with type 2 diabetes,...
- The Defense Logistics Agency awarded a delivery order valued at $10,058.42 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on October 22, 2025, with an ultimate completion date of October 23, 2025. This firm fixed-price, non-set-aside contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,369.73 delivery order for Trulicity 3 mg/0.5 mL pens on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price contract was executed with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes management medication, consistent with AmerisourceBergen's established role as a critical...
- The Defense Logistics Agency (DLA) awarded a $1,020.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens (0.5 mL units) on October 17, 2025, with an ultimate completion date of October 20, 2025. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The product will be...
- The Defense Logistics Agency awarded a $1,160.25 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitive award, which includes no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The pharmaceutical product...
- The Defense Logistics Agency (DLA) awarded a $3,863.83 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a completion date of September 9, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award to the vendor. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, serving as the company's corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,535.16 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 22, 2025, with completion targeted for August 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB26FULTYDelivery Order
The Defense Logistics Agency (DLA) awarded a $5,734.19 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on October 22, 2025, with an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Trulicity is a diabetes management medication, representing one of many pharmaceutical products AmerisourceBergen supplies through its federal contracting relationships. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. This prime pharmaceutical supply vehicle enables AmerisourceBergen to deliver a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems globally. As a major pharmaceutical distributor, AmerisourceBergen holds a significant position within the DLA's medical supply chain, serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through its extensive portfolio of brand-name and generic pharmaceutical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 10/22/25 |